Phenoconversion in pharmacogenomics: when medicines change the functional meaning of a genotype result

A CYP2D6 genotype does not change, but functional drug-metabolising activity can. Using an illustrative atomoxetine–terbinafine case and pharmacy scenarios, this article shows how pharmacists can recognise possible phenoconversion, assess patient safety, interpret a historical pharmacogenomic resu…